Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10335466 AADC polynucleotides for the treatment of parkinson's disease

Patent 10335466 was granted and assigned to Voyager Therapeutics on July, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Voyager Therapeutics

0

Current Assignee

Voyager Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Bernard Ravina0

Robert Kotin0

Adrian Philip Kells0

Date of Patent

July 2, 2019

0

Patent Application Number

155249860

Date Filed

November 5, 2015

0

Patent Citations Received

US Patent 11459558 Methods for using transcription-dependent directed evolution of AAV capsids

US Patent 10898585 Gene therapy for AADC deficiency

US Patent 11759506 AADC polynucleotides for the treatment of Parkinson's disease

US Patent 11865188 Gene therapy for AADC deficiency

0

US Patent 11975056 AADC polynucleotides for the treatment of Parkinson's disease

0

US Patent 12084653 Methods for using transcription-dependent directed evolution of AAV capsids

0

US Patent 12084654 Methods for using transcription-dependent directed evolution of AAV capsids

0

Patent Primary Examiner

0

Patent abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10335466 AADC polynucleotides for the treatment of parkinson's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.